sefulness of a test known as CBNAAT to diagnose TB of skin and to see if the bacteria will respond to a drug known as rifampici
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/01/022816
- Lead Sponsor
- DEPARTMENT OF DERMATOLOGY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All patients diagnosed clinically, histopathologically or using culture as any form of cutaneous tuberculosis.
2.Newly diagnosed patients of cutaneous TB and treatment started upto 8 weeks.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method